Trump Administration Files Patent Infringement Lawsuit Against Gilead Over HIV PrEP Drugs

New York Times: Trump Administration Sues Gilead, Maker of HIV-Prevention Drugs
“The Trump administration on Wednesday sued Gilead Sciences, a pharmaceutical company that sells HIV-prevention drugs that can cost patients up to $20,000 a year [in the U.S.], accusing the company of earning billions from research funded by taxpayers without paying taxpayers back. The government said the company infringed upon patents owned by the Department of Health and Human Services, and had refused attempts by the department to license its patents and collect royalties. The company sells two drugs, Truvada and Descovy, that can be taken once daily to prevent HIV infection, a strategy called pre-exposure prophylaxis, or PrEP…” (Victor, 11/7).

Additional coverage of the lawsuit is available from Daily Beast, HuffPost, and Washington Post.